| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00036 | 1 |